OTC: EVOH

EvoAir Holdings Inc.

CIK 0001700844 · SIC 3585 · Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip

Micro Revenue $285K Assets $44M as of Aug 23, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (WOLF 10-K) is open in full — no account needed.

S-1/A Filed Jul 24, 2026

Summary not yet generated.

10-Q Filed Jul 10, 2026 · Period ending May 31, 2026

Summary not yet generated.

Partner

Trade EVOH commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

10-Q Filed Apr 10, 2026 · Period ending Feb 28, 2026

Summary not yet generated.

10-Q Filed Jan 13, 2026 · Period ending Nov 30, 2025

Summary not yet generated.

8-K Filed Nov 12, 2025 · Period ending Nov 12, 2025

Summary not yet generated.

S-1/A Filed Nov 12, 2025

Summary not yet generated.

10-K Filed Nov 12, 2025 · Period ending Aug 31, 2025

Summary not yet generated.

S-1/A Filed Sep 19, 2025

Summary not yet generated.

S-1/A Filed Jul 29, 2025

Summary not yet generated.

10-K Filed Nov 29, 2024 · Period ending Aug 31, 2024

Summary not yet generated.

8-K Filed Sep 10, 2024 · Period ending Sep 10, 2024

Summary not yet generated.

8-K Filed Dec 13, 2023 · Period ending Dec 13, 2023

Summary not yet generated.

Latest financial statements

From 10-Q filed Jul 10, 2026 (period ending May 31, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

Description Three months ended May 31, 2026 Three months ended May 31, 2025 Nine months ended May 31, 2026 Nine months ended May 31, 2025
Revenue 123,574 37,306 211,613 160,359
Cost of revenue 116,751 8,505 201,580 168,681
Gross profit/(loss) 6,823 28,801 10,033 (8,322)
Operating expenses:
Selling and marketing expenses 617 5,566 4,712 20,264
General and administrative expenses 1,086,034 1,231,898 3,128,448 7,096,421
Total operating expenses 1,086,651 1,237,464 3,133,160 7,116,685
Loss from operation (1,079,828) (1,208,663) (3,123,127) (7,125,007)
Other income
Interest income/(expense) (43) (32) (55) 147
Other income 1,654 21,857 1,972 24,130
Total other income/(expense) 1,611 21,825 1,917 24,277
Loss from operation before income taxes (1,078,217) (1,186,838) (3,121,210) (7,100,730)
Income tax expenses - - - -
Net loss (1,078,217) (1,186,838) (3,121,210) (7,100,730)
Less: Net loss attributable to non-controlling interests (64,781) (69,014) (190,612) (221,683)
Net loss attributable to equity holders of the Company (1,013,436) (1,117,824) (2,930,598) (6,879,047)
Other comprehensive income/(loss):
Foreign currency translation adjustment 7,077 (103,798) (115,755) (89,560)
Total comprehensive loss (1,006,359) (1,221,622) (3,046,353) (6,968,607)
Less: net comprehensive income attributable to non-controlling interests 12,076 (21,508) (42,157) (9,273)
Net comprehensive loss attributable to equity holders of the Company (1,018,435) (1,200,114) (3,004,196) (6,959,334)
Net loss attributable to equity holders of the Company per common share:
Basic and diluted* (0.04) (0.04) (0.11) (0.26)
Weighted average number of common shares outstanding:
Basic and diluted 27,180,631 27,180,631 27,180,631 26,709,695

Condensed Consolidated Balance Sheets (Unaudited)

Description May 31, 2026 August 31, 2025
ASSETS
Current assets
Cash and cash equivalents 35,811 93,329
Accounts receivable, net 34,402 56,235
Inventories 310,960 316,508
Deposit, prepayments and other receivables 59,561 61,676
Total current assets 440,734 527,748
Non-current assets
Property, plant and equipment, net 226,862 264,557
Operating lease right-of-use assets 46,456 91,408
Deferred offering cost 3,233,652 3,225,464
Technology-related intangible assets, net 39,670,502 41,579,778
Total non-current assets 43,177,472 45,161,207
TOTAL ASSETS 43,618,206 45,688,955
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities
Accounts payable and accruals 577,456 548,194
Other payables 215,684 149,034
Deferred revenue 25,929 11,005
Hire purchase creditor - 4,852
Amounts due to shareholders 3,544,333 2,436,407
Operating lease liability current 50,342 63,262
Total current liabilities 4,413,744 3,212,754
Non-current liabilities
Operating lease liabilities - 34,774
Total non-current liabilities - 34,774
TOTAL LIABILITIES 4,413,744 3,247,528
Commitments and contingencies (Note 14) - -
Shareholders’ equity
Common stock, 250,000,000 authorized; $0.001 par value, 27,180,631 and 27,180,631 shares issued and outstanding as at May 31, 2026 and August 31, 2025* 27,181 27,181
Additional paid in capital 97,492,063 97,492,063
Accumulated other comprehensive loss (159,196) (85,598)
Accumulated deficit (56,959,317) (54,028,719)
Non-controlling interest (1,196,269) (963,500)
Total shareholders’ equity 39,204,462 42,441,427
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 43,618,206 45,688,955

Condensed Consolidated Statements of Cash Flows (Unaudited)

Description May 31, 2026 May 31, 2025
Cash flows from operating activities
Net loss (3,121,210) (7,100,730)
Adjustments for non-cash income and expenses:
Depreciation 93,738 84,729
Amortization 1,909,276 2,707,257
Stock based expense - 3,261,676
Changes in operating assets and liabilities:
Accounts receivables 21,833 3,419
Inventories 5,548 25,026
Deposit, prepayments and advances to suppliers 2,115 32,624
Operating lease right-of-use assets 44,952 61,007
Accounts payable and accruals 29,262 14,162
Deferred revenue 14,924 6,002
Operating lease liabilities (47,694) (63,847)
Other payables 66,650 68,580
Net cash used in operations (980,606) (900,095)
Cash flows from investing activity
Purchase of property, plant and equipment - (5,902)
Cash used in investing activity - (5,902)
Cash flows from financing activities
Loan from shareholders 1,107,926 972,045
Payments of hire purchase (4,852) (6,003)
Payment of deferred offering costs (8,188) (42,454)
Net cash generated from financing activities 1,094,886 923,588
Net decrease in cash and cash equivalents 114,280 17,591
Effect of exchange rate changes (171,798) (89,560)
Cash and cash equivalents at start of period 93,329 152,985
Cash and cash equivalents at end of period 35,811 81,016

Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗